Surgical Delay Is Not Warranted for Patients With Hip Fractures Receiving Non-Warfarin Anticoagulants

Area of Science:

• Orthopedic Surgery
• Geriatric Medicine
• Pharmacology

Background:

• Hip fractures are common in elderly patients.
• Anticoagulant medications (antiplatelet drugs, factor Xa inhibitors, direct thrombin inhibitors) are frequently used in this population.
• The optimal timing for surgical intervention in hip fracture patients on anticoagulants remains a clinical question.

Purpose of the Study:

• To evaluate surgical and clinical outcomes in hip fracture patients treated with anticoagulants within 48 hours versus those delayed more than 48 hours.
• To determine if early surgery increases risks such as blood loss, operative time, or complications.

Main Methods:

• Retrospective analysis of consecutive patients aged 55+ with operatively treated hip fractures.
• Inclusion of patients on antiplatelet drugs, factor Xa inhibitors, or direct thrombin inhibitors.
• Comparison of outcomes (blood loss, procedure time, transfusion, length of stay, complications) between early (<48 hours) and delayed (>48 hours) surgery groups.

Main Results:

• No significant differences in transfusion requirements, surgical blood loss, or operative time between early and delayed surgery groups.
• Anticoagulant type did not impact transfusion needs, blood loss, or surgery duration.
• Similar rates of complications and need for intensive care or step-down unit care in both early and delayed surgery cohorts.

Conclusions:

• Surgical fixation of hip fractures within 48 hours of admission is safe for patients on antiplatelet therapy, factor Xa inhibitors, or direct thrombin inhibitors.
• Early surgery does not elevate risks for transfusion, increased blood loss, longer operative time, or inpatient mortality.
• This finding supports timely surgical intervention for hip fracture patients regardless of their anticoagulant regimen.